|
🐜
|
Macitentan and morbidity and mortality in pulmonary arterial hypertension.
19 auth.
T. Pulido,
I. Adzerikho,
R. N. Channick,
M. Delcroix,
N. Galiè,
H. Ghofrani,
P. Jansa,
Z. Jing,
Franck-Olivier Le Brun,
S. Mehta,
...
Camilla Mittelholzer,
L. Perchenet,
B. Sastry,
O. Sitbon,
R. Souza,
A. Torbicki,
Xiaofeng Zeng,
L. J. Rubin,
G. Simonneau
|
10 |
2013 |
10
🐜
|
|
🐜
|
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension
11 auth.
R. Barst,
D. Ivy,
G. Gaitan,
A. Szatmári,
A. Rudziński,
Alberto E. Garcia,
...
B. Sastry,
T. Pulido,
Gary R. Layton,
M. Serdarevic-Pehar,
David L. Wessel
|
8 |
2012 |
8
🐜
|
|
🐜
|
Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.
22 auth.
Vallerie V Mclaughlin,
M. Hoeper,
R. N. Channick,
Kelly M Chin,
M. Delcroix,
S. Gaine,
H. Ghofrani,
P. Jansa,
Irene M. Lang,
S. Mehta,
...
T. Pulido,
B. Sastry,
G. Simonneau,
O. Sitbon,
R. Souza,
A. Torbicki,
V. Tapson,
L. Perchenet,
R. Preiss,
P. Verweij,
L. J. Rubin,
N. Galiè
|
6 |
2018 |
6
🐜
|
|
🐜
|
Effect of macitentan on hospitalizations: results from the SERAPHIN trial.
16 auth.
R. Channick,
M. Delcroix,
H. Ghofrani,
H. Ghofrani,
E. Hunsche,
P. Jansa,
F. Brun,
S. Mehta,
T. Pulido,
L. Rubin,
...
B. Sastry,
G. Simonneau,
O. Sitbon,
R. Souza,
A. Torbicki,
N. Galiè
|
6 |
2015 |
6
🐜
|
|
🐜
|
SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension
15 auth.
N. Galiè,
P. Jansa,
T. Pulido,
R. Channick,
M. Delcroix,
H. Ghofrani,
Franck-Olivier Le Brun,
S. Mehta,
L. Perchenet,
L. Rubin,
...
B. Sastry,
G. Simonneau,
O. Sitbon,
R. Souza,
A. Torbicki
|
6 |
2017 |
6
🐜
|
|
🐜
|
Macitentan Improves Health‐Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial
16 auth.
S. Mehta,
B. Sastry,
Rogério Souza,
A. Torbicki,
H. Ghofrani,
R. Channick,
M. Delcroix,
T. Pulido,
G. Simonneau,
J. Wlodarczyk,
...
L. Rubin,
P. Jansa,
E. Hunsche,
N. Galiè,
L. Perchenet,
O. Sitbon
|
5 |
2017 |
5
🐜
|
|
🐜
|
Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN
15 auth.
G. Simonneau,
R. Channick,
M. Delcroix,
N. Galiè,
H. Ghofrani,
P. Jansa,
Franck-Olivier Le Brun,
S. Mehta,
L. Perchenet,
T. Pulido,
...
B. Sastry,
O. Sitbon,
R. Souza,
A. Torbicki,
L. Rubin
|
5 |
2015 |
5
🐜
|
|
🐜
|
Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial
17 auth.
Rogério Souza,
R. Channick,
M. Delcroix,
N. Galiè,
H. Ghofrani,
H. Ghofrani,
P. Jansa,
F. Brun,
S. Mehta,
L. Perchenet,
...
T. Pulido,
B. Sastry,
O. Sitbon,
O. Sitbon,
A. Torbicki,
L. Rubin,
G. Simonneau
|
5 |
2018 |
5
🐜
|
|
🐜
|
Effect of Macitentan on Morbidity and Mortality in Pulmonary Arterial Hypertension (PAH): Results From the SERAPHIN Trial
16 auth.
L. Rubin,
T. Pulido,
R. Channick,
M. Delcroix,
N. Galiè,
H. Ghofrani,
P. Jansa,
F. Brun,
S. Mehta,
Camilla Mittelholzer,
...
L. Perchenet,
B. Sastry,
O. Sitbon,
R. Souza,
A. Torbicki,
G. Simonneau
|
4 |
2012 |
4
🐜
|
|
🐬
|
Sudden cardiac death after acute ST elevation myocardial infarction: insight from a developing country
H. Rao,
B. Sastry,
R. Korabathina,
Krishnam Raju
|
3 |
2012 |
3
🐬
|
